Akari Therapeutics Plchttps://investorshangout.com/Akari-Therapeutics-Plc-AKTX-89954/en-usSun, 13 Sep 2026 02:46:42 GMTCopyright InvestorsHangout.comwhytestocks: $AKTX News Article - Samir R. Patel, M.D. Appointed Interim CEO for Akari Therapeutics https://investorshangout.com/post/view?id=6689911https://investorshangout.com/post/view?id=6689911Wed, 01 May 2024 18:00:50 GMTwhytestocks: $AKTX News Article - Akari Therapeutics to Present at Biotech Showcase 2024 https://investorshangout.com/post/view?id=6653655https://investorshangout.com/post/view?id=6653655Thu, 14 Dec 2023 17:45:55 GMTwhytestocks: $AKTX News Article - Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Pathttps://investorshangout.com/post/view?id=6648993https://investorshangout.com/post/view?id=6648993Fri, 01 Dec 2023 19:56:01 GMTwhytestocks: $AKTX News Article - Akari Therapeutics Appoints Experienced Life Sciences Entrepreneur Samir R. Pathttps://investorshangout.com/post/view?id=6648991https://investorshangout.com/post/view?id=6648991Fri, 01 Dec 2023 19:50:55 GMTwhytestocks: $AKTX News Article - Akari Therapeutics to Present at Emerging Growth Conference https://investorshangout.com/post/view?id=6622886https://investorshangout.com/post/view?id=6622886Wed, 27 Sep 2023 12:16:15 GMTwhytestocks: $AKTX News Article - Expected earnings - Akari Therapeutics Plc https://investorshangout.com/post/view?id=6622614https://investorshangout.com/post/view?id=6622614Tue, 26 Sep 2023 16:55:50 GMTwhytestocks: $AKTX News Article - Akari Therapeutics Granted Nomacopan Orphan Drug Designation from the European https://investorshangout.com/post/view?id=6601428https://investorshangout.com/post/view?id=6601428Thu, 27 Jul 2023 16:30:47 GMTwhytestocks: $AKTX News Article - Akari Therapeutics Appoints Experienced Life Sciences Executive Wendy DiCicco ahttps://investorshangout.com/post/view?id=6597794https://investorshangout.com/post/view?id=6597794Wed, 19 Jul 2023 12:35:45 GMTwhytestocks: $AKTX News Article - Akari Therapeutics Provides Updates on Development of Nomacopan in Pediatric anhttps://investorshangout.com/post/view?id=6595677https://investorshangout.com/post/view?id=6595677Thu, 13 Jul 2023 12:05:45 GMTwhytestocks: $AKTX News Article - Akari Therapeutics Receives Positive Opinion on Orphan Drug Designation from thhttps://investorshangout.com/post/view?id=6593223https://investorshangout.com/post/view?id=6593223Thu, 06 Jul 2023 12:05:48 GMTwhytestocks: $AKTX News Article - Aspira Women's Health Names Torsten Hombeck as Chief Financial Officer https://investorshangout.com/post/view?id=6575571https://investorshangout.com/post/view?id=6575571Tue, 16 May 2023 20:20:46 GMTwhytestocks: $AKTX News Article - Akari Therapeutics Reports Full-Year 2022 Financial Results and Highlights https://investorshangout.com/post/view?id=6568877https://investorshangout.com/post/view?id=6568877Mon, 01 May 2023 15:30:47 GMTwhytestocks: $AKTX News Article - Akari Therapeutics Announces a Case Study from the Phase 3 Part A Clinical Triahttps://investorshangout.com/post/view?id=6556163https://investorshangout.com/post/view?id=6556163Mon, 03 Apr 2023 16:30:50 GMTwhytestocks: $AKTX News Article - Akari Therapeutics Announces Acceleration of the Phase 3 Clinical Trial of Nomahttps://investorshangout.com/post/view?id=6535873https://investorshangout.com/post/view?id=6535873Mon, 13 Feb 2023 13:05:45 GMTwhytestocks: $AKTX News Article - Akari Therapeutics Reports Second Quarter 2022 Financial Results and Highlightshttps://investorshangout.com/post/view?id=6477265https://investorshangout.com/post/view?id=6477265Tue, 27 Sep 2022 18:25:49 GMTwhytestocks: $AKTX News Article - Akari Therapeutics Announces Publication of Phase II Data of Investigational Nohttps://investorshangout.com/post/view?id=6400135https://investorshangout.com/post/view?id=6400135Tue, 10 May 2022 18:45:51 GMTwhytestocks: $AKTX News Article - Akari Presents Results from Two Preclinical Development Programs of Long-Actinghttps://investorshangout.com/post/view?id=6398967https://investorshangout.com/post/view?id=6398967Mon, 09 May 2022 12:35:52 GMTznewcar1: S@1.3? f52M LL@.87 and recent H@$4https://investorshangout.com/post/view?id=6347239https://investorshangout.com/post/view?id=6347239Fri, 18 Feb 2022 16:49:18 GMTwhytestocks: $AKTX News Article - Akari Therapeutics to Present Its Phase III Plans for Nomacopan in Patients withttps://investorshangout.com/post/view?id=6237424https://investorshangout.com/post/view?id=6237424Fri, 10 Sep 2021 17:15:51 GMTwhytestocks: $AKTX News Article - Akari Therapeutics Announces Initiation of Pivotal Phase III Trial of Nomacopanhttps://investorshangout.com/post/view?id=6106037https://investorshangout.com/post/view?id=6106037Mon, 12 Apr 2021 14:45:48 GMTwhytestocks: $AKTX News Article - Akari Therapeutics to Participate in Two September Virtual Investor Conferenceshttps://investorshangout.com/post/view?id=5889669https://investorshangout.com/post/view?id=5889669Thu, 10 Sep 2020 16:25:48 GMTwhytestocks: $AKTX News Article - Akari Therapeutics Announces Appointment of Chief Financial Officer https://investorshangout.com/post/view?id=5812859https://investorshangout.com/post/view?id=5812859Wed, 01 Jul 2020 16:25:53 GMTznewcar1: AKTX 24% v3,8M c2.1601 f21M H2.35 S? EOD pushhttps://investorshangout.com/post/view?id=5640101https://investorshangout.com/post/view?id=5640101Sat, 11 Jan 2020 00:17:13 GMTwhytestocks: $AKTX News Article - Akari Therapeutics Announces Positive Interim Data from Phase III Paroxysmal Nohttps://investorshangout.com/post/view?id=5639563https://investorshangout.com/post/view?id=5639563Fri, 10 Jan 2020 14:55:42 GMTznewcar1: Hey whytestocks AKTX has been gaping up and failing all year. seems odd has 21M share float so a lihttps://investorshangout.com/post/view?id=5634330https://investorshangout.com/post/view?id=5634330Sat, 04 Jan 2020 20:03:05 GMTwhytestocks: $AKTX News Article - Akari Therapeutics Announces Pivotal Phase III Trial Design of Nomacopan in Pedhttps://investorshangout.com/post/view?id=5606767https://investorshangout.com/post/view?id=5606767Mon, 02 Dec 2019 14:55:42 GMTznewcar1: AKTX 62% v34,3M c2.92 f18,8M big morning gap up S@2.30 with EOD BOhttps://investorshangout.com/post/view?id=5510799https://investorshangout.com/post/view?id=5510799Wed, 14 Aug 2019 21:41:23 GMTwhytestocks: $AKTX News Article - Akari Therapeutics announces new data demonstrating synergistic benefits of nomhttps://investorshangout.com/post/view?id=5505982https://investorshangout.com/post/view?id=5505982Fri, 09 Aug 2019 13:55:41 GMTwhytestocks: $AKTX News Article - Akari Reports Fourth Quarter and Full Year 2018 Financial Results and Business https://investorshangout.com/post/view?id=5420684https://investorshangout.com/post/view?id=5420684Tue, 23 Apr 2019 20:05:40 GMTwhytestocks: $AKTX News Article - Akari Therapeutics Announces Positive Initial Phase II Clinical Data in Orphan https://investorshangout.com/post/view?id=5419997https://investorshangout.com/post/view?id=5419997Tue, 23 Apr 2019 12:35:40 GMTwhytestocks: $AKTX News Article - Advancing Clinical Trials For Leukemia Patients Is Helping Improve Survival Rathttps://investorshangout.com/post/view?id=5378894https://investorshangout.com/post/view?id=5378894Thu, 14 Mar 2019 13:55:39 GMTstickytape: This stock is overbought. may gap up to 7.50 that is it.... decay time like a cheap options contrhttps://investorshangout.com/post/view?id=5378543https://investorshangout.com/post/view?id=5378543Thu, 14 Mar 2019 02:56:56 GMTznewcar1: 224% v78,5M c5.9 f15,806,934 Saw this @3 then the BO3.40 sent this to >$4 then $5 came back to S@4.4https://investorshangout.com/post/view?id=5378246https://investorshangout.com/post/view?id=5378246Wed, 13 Mar 2019 20:05:26 GMTwhytestocks: $AKTX News Article - Positive FDA Meeting Outlines Path Ahead for Akari Therapeutics's Coversin in Hhttps://investorshangout.com/post/view?id=5377941https://investorshangout.com/post/view?id=5377941Wed, 13 Mar 2019 16:50:40 GMTHattlem: Pulverized, how pathetic. can't believe they haven't halted this already. It should not be trading. https://investorshangout.com/post/view?id=3116070https://investorshangout.com/post/view?id=3116070Thu, 20 Aug 2015 14:01:21 GMTjones2000: $CLTX Despite seeing $AQXP surprising everyone with a second HUGE up day, are you guy somewhat confihttps://investorshangout.com/post/view?id=3115726https://investorshangout.com/post/view?id=3115726Thu, 20 Aug 2015 10:35:48 GMTJake13: CLTX Stock year to date has changed +28.54% percent. +14.47% in the last 30 days. $CLTX Celsus Thhttps://investorshangout.com/post/view?id=2649399https://investorshangout.com/post/view?id=2649399Fri, 13 Feb 2015 06:38:33 GMTchartguy89: CLTX 6.17 Celsus Therapeutics Plc. Stock Charts $CLTX Last Updated: 02/12/15 Last price: 6.17https://investorshangout.com/post/view?id=2649338https://investorshangout.com/post/view?id=2649338Fri, 13 Feb 2015 06:26:12 GMTJake13: CLTX Stock year to date has changed +26.67% percent. +20.40% in the last 30 days. $CLTX Celsus Thhttps://investorshangout.com/post/view?id=2637449https://investorshangout.com/post/view?id=2637449Wed, 11 Feb 2015 05:14:33 GMTchartguy89: CLTX 6.08 Celsus Therapeutics Plc. Stock Charts $CLTX Last Updated: 02/10/15 Last price: 6.08https://investorshangout.com/post/view?id=2637446https://investorshangout.com/post/view?id=2637446Wed, 11 Feb 2015 05:13:57 GMT